Cargando…

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria

Stone formation and nephrocalcinosis are both very common features of primary hyperoxaluria, yet the extent of each disease varies markedly between patients. Here we studied whether kidney damage from nephrocalcinosis and/or stone related events contributed to end stage kidney disease (ESKD). Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Xiaojing, Bergstralh, Eric J., Mehta, Ramila A., Vrtiska, Terri J., Milliner, Dawn S., Lieske, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344931/ https://www.ncbi.nlm.nih.gov/pubmed/25229337 http://dx.doi.org/10.1038/ki.2014.298

Ejemplares similares

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2020)

Correction to: Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2021)

Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant
por: Genena, Kareem M., et al.
Publicado: (2023)

Kidney stones are common after bariatric surgery
por: Lieske, John C., et al.
Publicado: (2014)

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
por: Shah, Ronak Jagdeep, et al.
Publicado: (2020)

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
por: Sas, David J., et al.
Publicado: (2021)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease
por: Marschner, Julian A., et al.
Publicado: (2018)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Clinical and molecular characterization of primary hyperoxaluria in Egypt
por: Soliman, Neveen A., et al.
Publicado: (2022)

Molecular Diagnosis of Primary Hyperoxaluria Type 1 and Distal Renal Tubular Acidosis in Moroccan Patients With Nephrolithiasis and/or Nephrocalcinosis
por: Fatima, Abdouss, et al.
Publicado: (2022)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Primary hyperoxaluria type 1: novel therapies at a glance
por: Bacchetta, Justine, et al.
Publicado: (2022)

New Insights Regarding Organ Transplantation in Primary Hyperoxaluria Type 1
por: Sas, David J., et al.
Publicado: (2021)

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
por: Milliner, Dawn S., et al.
Publicado: (2021)

Retraction: Molecular Diagnosis of Primary Hyperoxaluria Type 1 and Distal Renal Tubular Acidosis in Moroccan Patients With Nephrolithiasis and/or Nephrocalcinosis
por: Fatima, Abdouss, et al.
Publicado: (2022)

Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intra-renal calcification
por: Linnes, Michael P., et al.
Publicado: (2013)

Diagnostic policies on nephrolithiasis/nephrocalcinosis of possible genetic origin by Italian nephrologists: a survey by the Italian Society of Nephrology with an emphasis on primary hyperoxaluria
por: Ferraro, Pietro Manuel, et al.
Publicado: (2023)

Genetic Background but Not Intestinal Microbiota After Co-Housing Determines Hyperoxaluria-Related Nephrocalcinosis in Common Inbred Mouse Strains
por: Ma, Qiuyue, et al.
Publicado: (2021)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Is Genotype the Major Outcome Parameter of Kidney Failure in Patients With Primary Hyperoxaluria Type 1?
por: Vali, P. Sharmas, et al.
Publicado: (2023)

Application of multivariate joint modeling of longitudinal biomarkers and time-to-event data to a rare kidney stone cohort
por: Vaughan, Lisa E., et al.
Publicado: (2022)

Nephrocalcinosis in primary Sjögren's syndrome
por: Gharbi, Chems, et al.
Publicado: (2014)

Limited Treatment Options in Primary Hyperoxaluria with Renal Failure
por: Geiger, Kyle, et al.
Publicado: (2020)

Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt
por: Jacob, Dorrit E., et al.
Publicado: (2013)

Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
por: Pfau, Anja, et al.
Publicado: (2021)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Familial mixed nephrocalcinosis as a cause of chronic kidney failure: two case reports
por: de Arruda, Pedro Francisco Ferraz, et al.
Publicado: (2014)

Clinical outcomes of nephrocalcinosis in preschool-age children: association between nephrocalcinosis improvement and long-term kidney function
por: Woo, Hyun Ah, et al.
Publicado: (2023)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

A case of failure to thrive secondary to primary hyperoxaluria type 1
por: Stern, Rachel, et al.
Publicado: (2020)

Nephrocalcinosis in preterm neonates
por: Schell-Feith, Eveline A., et al.
Publicado: (2010)

Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation
por: Singh, Prince, et al.
Publicado: (2020)

Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review
por: Cai, Ruiming, et al.
Publicado: (2019)

Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
por: Goldfarb, David S., et al.
Publicado: (2023)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022)

Primary hyperoxaluria: a case series
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hufn70h45a5d0obbfh85v7fjbn